Log In
Print this Print this

Gadavist, Gadovist, gadobutrol

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionGadolinum-based contrast agent
Molecular Target Not applicable
Mechanism of ActionDiagnostic; Imaging agent
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationRadiologic imaging
Indication DetailsMagnetic resonance angiography (MRA) contrast agent to evaluate known or suspected supra-aortic or renal artery disease; Magnetic resonance imaging (MRI); MRI contrast agent to evaluate breast cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today